SCHEMBL2912649

SCHEMBL2912649

COC(C1CCCCC1)C1(C(C(=O)NC2CCCC2)C2CCCCC2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 6/20 0.38
RAB9A P51151 6/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP2C9 P11712 1/20 0.35
KCNH2 Q12809 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
EPHX2 P34913 2/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908003 1.00 KMT2A (0.39) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2914472 0.84 MEN1 (0.36) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2913162 0.83 KMT2A (0.42) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2910028 0.83 SMN1; SMN2 (0.45) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2913981 0.83 ALDH1A1 (0.46) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2912667 0.83 ALDH1A1 (0.46) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2915685 0.81 NPC1 (0.39) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2915018 0.78 SMN1; SMN2 (0.41) KMT2AMEN1RAB9ASMN1; SMN2TSHR
SCHEMBL2913040 0.78 TSHR (0.44) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2912870 0.78 ALDH1A1 (0.43) KMT2AMEN1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed